Newly Developed Barrett’s Esophagus after Subtotal Esophagectomy

Background and Study Aims: More detailed information regarding the early mucosal events that lead to intestinal metaplasia would be very beneficial for understanding the pathogenesis of Barrett’s esophagus (BE). Gastroesophageal reflux and duodenogastroesophageal reflux play a major role in the pathogenesis of Barrett’s esophagus. The aim of this study was to investigate the prevalence of newly developed BE in patients who had previously undergone a subtotal esophagectomy - a clinical condition characterized by the absence of a lower esophageal sphincter and massive gastroesophageal reflux.
Patients and Methods: A retrospective examination was carried out on all patients who underwent subtotal esophagectomy (n = 87) listed in our institution’s computer files from 1995 to 2000. Twenty-one patients were excluded due to missing data or no upper gastrointestinal endoscopy after surgery.

Results: Based on the Savary-Miller classification, 47 patients developed either type I (n = 2), II (n = 8), III (n = 11) or IV (n = 26) esophagitis after surgery. Newly developed BE was observed in nine patients (13.5 %) after subtotal esophagectomy (median time to diagnosis: 489 days, range 43 - 1172). None of the patients had persistent BE immediately after surgery, and two of the patients with newly developed BE had had no history of BE before surgery or at the time of surgery. Proton-pump inhibitor therapy after surgery and neoadjuvant chemotherapy did not appear to influence the development of BE after subtotal esophagectomy.
Conclusions: Newly developed BE after subtotal esophagectomy may provide further insights into the early mucosal events that lead to intestinal metaplasia and into the roles of gastroesophageal and duodenoesophageal reflux in the pathogenesis of BE.

References

• 1 Spechler S J, Goyal R K. The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett.  Gastroenterology. 1996;  110 614-621
• 2 Spechler S J. Barrett’s oesophagus: diagnosis and management.  Baillière’s Best Pract Res Clin Gastroenterol. 2000;  14 857-879
• 3 Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.  N Engl J Med. 1999;  340 825-831
• 4 Jankowski J A, Wright N A, Meltzer S J. et al . Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.  Am J Pathol. 1999;  154 965-973
• 5 Barrett M T, Sanchez C A, Prevo L J. et al . Evolution of neoplastic cell lineages in Barrett oesophagus.  Nat Genet. 1999;  22 106-109
• 6 Koop H. Gastroesophageal reflux disease and Barrett’s esophagus.  Endoscopy. 2002;  33 257-261
• 7 Triadafilopoulos G. Acid and bile reflux in Barrett’s esophagus: a tale of two evils.  Gastroenterology. 2001;  121 1502-1506
• 8 Avidan B, Sonnenberg A, Schnell T G, Sontag S J. Gastric surgery is not a risk for Barrett’s esophagus or esophageal adenocarcinoma.  Gastroenterology. 2001;  121 1281-1285
• 9 Parrilla P, Liron R, Martinez d e . et al . Gastric surgery does not increase the risk of developing Barrett’s esophagus.  Am J Gastroenterol. 1997;  92 960-963
• 10 Sears R J, Champion G L, Richter J E. Characteristics of distal partial gastrectomy patients with esophageal symptoms of duodenogastric reflux.  Am J Gastroenterol. 1995;  90 211-215
• 11 Vaezi M F, Richter J E. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease.  Gastroenterology. 1996;  111 1192-1199
• 12 Marshall R E, Anggiansah A, Owen W A, Owen W J. Investigation of oesophageal reflux symptoms after gastric surgery with combined pH and bilirubin monitoring.  Br J Surg. 1999;  86 271-275
• 13 Champion G, Richter J E, Vaezi M F. et al . Duodenogastroesophageal reflux: relationship to pH and importance in Barrett’s esophagus.  Gastroenterology. 1994;  107 747-754
• 14 Ouatu-Lascar R, Fitzgerald R C, Triadafilopoulos G. Differentiation and proliferation in Barrett’s esophagus and the effects of acid suppression.  Gastroenterology. 1999;  117 327-335
• 15 Martinez de Haro L, Ortiz A, Parrilla P. et al . Intestinal metaplasia in patients with columnar lined esophagus is associated with high levels of duodenogastroesophageal reflux.  Ann Surg. 2001;  233 34-38
• 16 Marshall R E, Anggiansah A, Owen W A. et al . The extent of duodenogastric reflux in gastro-oesophageal reflux disease.  Eur J Gastroenterol Hepatol. 2001;  13 5-10
• 17 Kahaleh M, van Laethem J L, Nagy N. et al . Long-term follow-up and factors predictive of recurrence in Barrett’s esophagus treated by argon plasma coagulation and acid suppression.  Endoscopy. 2002;  34 950-955
• 18 Spechler S J. Clinical practice: Barrett’s esophagus.  N Engl J Med. 2002;  346 836-842